跳至主要内容
临床试验/CTRI/2010/091/001046
CTRI/2010/091/001046已完成3 期

An open labeled, randomized, comparative study to evaluate the Efficacy and Safety of Etimicin Sulphate v/s Amikacin in patients suffering from various bacterial infections

Venus Remedies Limited0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Male and female subjects in the age group of above 18 years till 60 years shall be selected.
  • Presence of an abnormal chest x-ray (CXR) as determined by the primary care team in case of LRTI patients
  • Clinically diagnosed subjects with Respiratory tract infections mainly LRTI (Lower respiratory tract infections) , skin & skin structure infections, UTI (Urinary tract infections), surgical infections
  • Patients or legal guardian or LAR (Legally acceptable representative) ready to give written informed consent.

排除标准

  • History of hypersensitivity reaction or any specific contraindication to Aminoglycosides or Etimicin or Amikacin
  • Presence of hepatic or renal disorders
  • History of hearing loss
  • Pregnant or lactating women

研究者

相似试验